Skip to content

Korean Coronary Bifurcation Stenting (COBIS) Registry II

Korean Coronary Bifurcation Stenting (COBIS) Registry II

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01642992
Enrollment
2873
Registered
2012-07-17
Start date
2011-01-31
Completion date
2012-04-30
Last updated
2013-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Bifurcation Lesion

Keywords

Coronary bifurcation lesion, Drug-eluting stent

Brief summary

The COBIS II registry is a multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea. From 18 major coronary intervention centers in Korea, a total of 2,873 patients were enrolled in this database between January 2003 and December 2009. The aim of the study was to investigate long-term clinical results and predictors of adverse outcomes after percutaneous coronary intervention with drug-eluting stents for coronary bifurcation lesions in South Korea.

Interventions

None listed

Sponsors

Hyeon-Cheol Gwon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>= 18 years * Any type of bifurcation lesion in major epicardial artery * Side branch reference diameter \>= 2.3 mm and at least stentable with 2.5 mm stent * Treated with drug-eluting stent

Exclusion criteria

* Protected left main disease previous CABG for LAD or LCX territory * Cardiogenic Shock * History of CPR in the same hospitalization

Design outcomes

Primary

MeasureTime frame
Incidence of the composite outcomes of cardiac death, target vessel-related myocardial infarction, or target-lesion revascularization3 years

Secondary

MeasureTime frame
Cardiac death3 years
Myocardial infarction3 years
Target lesion revascularization3 years
Stent thrombosis3 years

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026